www.fdanews.com/articles/68538-rohto-morishita-jintan-to-establish-joint-sales-company
Rohto, Morishita Jintan to Establish Joint Sales Company
February 8, 2005
Rohto Pharmaceutical and Morishita Jintan have basically agreed to jointly set up a new sales company on July 1. To be capitalized at 90 million yen ($865,000), Medicare Systems will be owned 70 percent by Rohto and 30 percent by Morishita. The parent companies will outsource part of their operations to the new company. Rohto will transfer its internal medicines including gastrointestinal drugs, health foods and test agents, while Jintan will shift its retail products such as the Jintan breath freshener.
Japan Corporate News